The challenges in developing new antibiotics have left us vulnerable to growing antimicrobial resistance. The lack of investment and slow movement in the development pipeline mean no replacements for ineffective antibiotics as drug resistance spreads. Without new antibiotics and treatments, an estimated 10 million people a year will die by 2050. What novel therapies and technologies can we utilize to bolster the human microbiome and combat antimicrobial resistance? And how can we effectively save the new antibiotics currently in development for future generations?
Moderator
Margaret Hamburg
Foreign Secretary, National Academy of Medicine
Speakers
Matthew Hepburn
Program Manager, Biological Technologies Office, DARPA
Peter Jackson
Executive Director, AMR Centre
Nancy Knight
Director, Division of Global Health Protection, Centers for Disease Control and Prevention
Jeanette Mucha
Co-Founder and CEO, SciBac Inc.
Peter Piot
Director and Handa Professor of Global Health, London School of Hygiene & Tropical Medicine